Literature DB >> 9403730

Host modifier genes affect mouse autoimmunity induced by the lpr gene.

Y Wang1, M Nose, T Kamoto, M Nishimura, H Hiai.   

Abstract

A defect in apoptotic signal transmission through CD95 is an essential genetic mechanism for lymphoproliferation and autoimmunities in lpr or gld mice. However, disease manifestations are largely affected by the host genetic background. To identify and map such host genes modifying lpr gene effect, ie, the lpr modifier (Lprm) genes, 82 MRL/lpr x (MRL/lpr x C3H/lpr) F1 mice were subjected to immunopathological and genetical analyses. High-grade vasculitis and glomerulonephritis among backcross mice were observed in separate groups of mice. Microsatellite analysis revealed that there were two host genes affecting the occurrence of vasculitis, Lprm1 (chromosome 4) and Lprm2 (chromosome 3). A recessive MRL allele at Lprm1 enhanced vasculitis to occur in both sexes, whereas that of Lprm2 inhibited its development selectively in females. Genotype combinations of these two genes explained the severity of vasculitis in crosses of MRL/lpr and C3H/lpr mice and also the vasculitis-prone recombinant inbred strain McH5/lpr. A recessive MRL allele at Lprm3 (chromosome 14) suppressed glomerulonephritis. The weight of the spleen was increased by a recessive MRL allele at Lprm4 (chromosome 5) yielding a logarithm of odds score of 2.02 in a quantitative trait locus analysis. In contrast, the weight of axillary lymph nodes was increased by a recessive MRL allele at a locus on chromosome 2, but its presence was not supported by the quantitative trait locus analysis. The titer of anti-dsDNA autoantibody was controlled by the locus Lprm5 on chromosome 16, which had an logarithm of odds score of 3.41. Possible candidate genes for Lprm genes deduced from their map locations are discussed and compared with the autoimmunity genes reported thus far. In conclusion, autoimmune disease manifestations by the lpr mutation are affected by multiple host genes separately.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403730      PMCID: PMC1858355     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Arteritis in a novel congenic strain of mice derived from MRL/Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production.

Authors:  M Nose; M Nishimura; M R Ito; J Toh; T Shibata; T Sugisaki
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 2.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

3.  Induction of various autoantibodies by mutant gene lpr in several strains of mice.

Authors:  S Izui; V E Kelley; K Masuda; H Yoshida; J B Roths; E D Murphy
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

4.  Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities.

Authors:  J H Berden; L Hang; P J McConahey; F J Dixon
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

5.  The gene encoding the T-cell receptor alpha-chain maps close to the Np-2 locus on mouse chromosome 14.

Authors:  Z Dembić; W Bannwarth; B A Taylor; M Steinmetz
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

6.  MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations.

Authors:  E S Lander; P Green; J Abrahamson; A Barlow; M J Daly; S E Lincoln; L A Newberg; L Newburg
Journal:  Genomics       Date:  1987-10       Impact factor: 5.736

7.  Trypanosoma cruzi: susceptibility in mice carrying mutant gene lpr (lymphoproliferation).

Authors:  M H Boyer; R Hoff; T L Kipnis; E D Murphy; J B Roths
Journal:  Parasite Immunol       Date:  1983-03       Impact factor: 2.280

8.  Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice.

Authors:  S Hirose; G Ueda; K Noguchi; T Okada; I Sekigawa; H Sato; T Shirai
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

9.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Authors:  S Yonehara; A Ishii; M Yonehara
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  12 in total

1.  Identification and characterization of a lupus suppressor 129 locus on chromosome 3.

Authors:  Francesco Carlucci; Liliane Fossati-Jimack; Ingrid E Dumitriu; Yasin Heidari; Mark J Walport; Marta Szajna; Paramita Baruah; Oliver A Garden; H Terence Cook; Marina Botto
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

2.  Gene defects in the soma: some get it and some don't!

Authors:  Bernice Lo; Michael J Lenardo
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

3.  An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.

Authors:  M-C Zhang; N Misu; H Furukawa; Y Watanabe; M Terada; H Komori; T Miyazaki; M Nose; M Ono
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

4.  A New Zealand Black-derived locus suppresses chronic graft-versus-host disease and autoantibody production through nonlymphoid bone marrow-derived cells.

Authors:  Zhiwei Xu; Anusha Vallurupalli; Christopher Fuhrman; David Ostrov; Laurence Morel
Journal:  J Immunol       Date:  2011-02-18       Impact factor: 5.422

5.  A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas(lprcg) mice.

Authors:  Y Zhang; T Yasuda; C R Wang; T Yoshimoto; H Nagase; M Takamoto; A Tsubura; M Kimura; A Matsuzawa
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

6.  Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients.

Authors:  T Grodzicky; J B Bussel; K B Elkon
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

7.  TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.

Authors:  Kevin M Nickerson; Sean R Christensen; Jonathan Shupe; Michael Kashgarian; Daniel Kim; Keith Elkon; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

8.  A new mouse model of metabolic syndrome and associated complications.

Authors:  Yun Wang; Yue Zheng; Patsy M Nishina; Jürgen K Naggert
Journal:  J Endocrinol       Date:  2009-04-27       Impact factor: 4.286

9.  Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus.

Authors:  Rujuan Dai; Yan Zhang; Deena Khan; Bettina Heid; David Caudell; Oswald Crasta; S Ansar Ahmed
Journal:  PLoS One       Date:  2010-12-10       Impact factor: 3.240

10.  Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4).

Authors:  I Smirnova; A Poltorak; E K Chan; C McBride; B Beutler
Journal:  Genome Biol       Date:  2000-04-27       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.